How to Govern AI in Life Sciences: Validation, Compliance & Risk Management?
Note: This is the transcript of Episode 2 of the Infiligence Pulse podcast.
You can listen to the full episode here.
How life sciences organizations can adopt AI without compromising validation rigor, regulatory compliance, data integrity, or human judgment?
Artificial intelligence is rapidly becoming part of how life sciences organizations work. From medical writing and study protocols to data analysis, software development, workflow automation, and AI agents, organizations are moving beyond experimentation and into real-world adoption.
But AI governance in life sciences introduces a fundamental challenge: how do you govern systems whose outputs can vary without compromising the rigor expected in a regulated industry?
The answer is not to eliminate governance or force generative AI into traditional software validation models.
It is to build risk-based AI governance into the workflow itself—with appropriate validation, compliance controls, continuous monitoring, and human oversight.
What Is AI Governance in Life Sciences?
AI governance in life sciences is the framework used to control how AI systems are designed, validated, deployed, monitored, and used within regulated processes.
It addresses questions such as:
- What is the AI allowed to do?
- What data can it access?
- How much authority does it have?
- What happens when its output is incorrect?
- Where is human review required?
- How is performance monitored?
- What evidence must be retained?
- How can the organization demonstrate that the AI remains fit for its intended use?
These questions become increasingly important as organizations move from using AI as a productivity tool to embedding AI directly into business and scientific workflows.
The goal is not simply to govern the model.
The goal is to govern the entire process in which the model operates.
Why Traditional AI Validation Approaches Need to Evolve?
Traditional software validation was largely designed around deterministic systems.
A defined input produces an expected output, and testing verifies that the system consistently behaves as intended.
Generative AI introduces variability.
The same prompt can sometimes produce different outputs on different runs, while both outputs may still be accurate and appropriate.
This creates a fundamental change in how AI validation in life sciences should be approached.
Instead of asking:
“Did the AI produce exactly the same answer?”
The more meaningful question is:
“Did the AI produce an acceptable answer, and do we have controls capable of detecting an unacceptable one?”
That distinction is critical.
The objective of validation has not changed. Organizations still need to demonstrate that systems work as intended and that risks are appropriately controlled.
What changes is the evidence and testing strategy used to demonstrate that outcome.
From Deterministic Testing to Outcome-Based AI Validation
Early approaches to generative AI validation often attempted to apply deterministic testing principles directly to LLMs.
That creates unnecessary friction.
A better approach starts with the intended outcome.
For example, suppose an AI system is being used to support medical writing. The objective is not necessarily to force the model to produce identical wording every time.
Instead, validation could assess whether the output:
- Meets defined quality criteria
- Uses appropriate source information
- Avoids known error types
- Maintains required context
- Meets applicable compliance requirements
- Is reviewed by the appropriate human
- Produces sufficient evidence for traceability
This shifts validation from output sameness to controlled quality.
The process becomes:
Generate → Evaluate → Review → Correct → Approve
The exact evaluation criteria will vary by use case, but the principle remains consistent.
What Is Proportional AI Governance?
Not every AI application presents the same level of risk.
An AI agent that summarizes meeting notes does not carry the same consequence as an AI agent involved in developing a study protocol or supporting adverse event reporting.
This is where risk-based AI governance becomes important.
The level of governance should be proportional to:
- The authority given to the AI
- The consequence of an incorrect output or action
AI Authority
An AI system might:
- Provide information
- Generate recommendations
- Recommend a next-best action
- Take an action with human approval
- Operate with greater autonomy
Potential Consequence
The workflow may be:
- Non-critical
- Medium criticality
- High criticality
Together, these dimensions provide a practical AI governance framework for determining the appropriate level of validation, monitoring, oversight, and intervention.
For example, an AI meeting summarizer may require relatively limited controls compared with an AI system supporting a safety-related workflow.
The principle is straightforward:
The greater the authority and consequence, the stronger the governance required.
Why Risk Matters More as AI Moves Closer to Human Safety?
Life sciences is fundamentally different from many other industries because technology can ultimately influence human health and safety.
Organizations cannot simply treat AI implementation as an A/B experiment where failure is acceptable.
That makes consequence-based governance particularly important.
An AI system generating administrative content may operate under one control framework.
An AI system supporting study protocol development, medical writing, safety reporting, clinical workflows, or regulatory processes may require significantly stronger validation and human oversight.
This is why AI risk management in life sciences should begin with the workflow and its potential consequences—not simply the model being used.
AI Is Human-Adjacent, Not Human-Replacing
One of the most important principles of AI governance is maintaining clear human accountability.
AI systems and LLMs are not people.
They can operate alongside people, support people, and increasingly perform tasks that previously required significant human effort. But they should not automatically replace human responsibility in consequential life sciences processes.
The person accountable for the process remains accountable for the outcome.
That includes appropriate human oversight, review, intervention, and final decision-making.
This creates what can be described as a human-adjacent AI framework.
AI works alongside the workforce rather than becoming an independent source of accountability.
Treating an AI System Like a New Employee
A useful analogy is onboarding a new employee.
A new employee may have excellent knowledge and technical skills but still need to learn the organization's processes, quality expectations, and potential pitfalls.
You would not immediately give that employee unlimited authority.
You would:
- Review their experience.
- Train them.
- Define their responsibilities.
- Monitor their performance.
- Review their work.
- Increase their authority as they demonstrate competence.
- Intervene when performance falls below expectations.
The same approach can inform AI governance.
An AI agent can be evaluated, monitored, graded, qualified, and progressively given greater authority.
If performance deteriorates, its authority can be reduced.
If it fails defined quality thresholds, it can be retrained or requalified.
The critical capabilities are:
Watch → Intervene → Halt → Retrain → Demote → Requalify
This creates a controlled AI lifecycle instead of treating deployment as the end of validation.
How Do You Validate Generative AI in Life Sciences?
The most effective approach is to validate the overall process, not simply the AI model.
Consider medical writing.
A regulatory submission typically passes through multiple contributors, reviews, quality checks, and approvals. One person does not simply generate the document and submit it without oversight.
The same process thinking can be applied when AI generates content.
The AI may introduce different types of errors than a human, so the checks need to account for those differences.
But the underlying validation principle remains:
Define → Generate → Check → Review → Correct → Approve
This allows organizations to incorporate generative AI while maintaining established quality and accountability mechanisms.
AI Validation Should Focus on the Entire Workflow
A broader AI validation framework should consider:
Intended Use
Clearly define what the AI system is intended to do—and what it is not permitted to do.
AI Authority
Establish whether the AI provides information, recommendations, decisions, or actions.
Human Oversight
Define where human review is mandatory and who has decision authority.
Output Quality
Establish measurable acceptance criteria appropriate to the use case.
Data Access
Document what information the system can access and how that information is handled.
Traceability
Capture sufficient evidence to reconstruct how an output was generated and reviewed.
Continuous Monitoring
Monitor performance after deployment rather than treating validation as a one-time event.
Using Existing Compliance Principles for AI Governance
Life sciences organizations do not necessarily need to create an entirely new compliance universe for AI.
Existing principles can provide a strong foundation.
ALCOA+, for example, establishes expectations around data integrity, including characteristics such as attributable, legible, contemporaneous, original, accurate, complete, consistent, enduring, and available.
These principles can be extended into AI-enabled workflows.
An AI governance system can capture:
- What data the AI accessed
- What inputs were provided
- Which model and version were used
- What instructions governed the task
- What output was generated
- What security controls applied
- What authority the AI had
- What human review occurred
- What decision followed
- Whether the result met defined requirements
This information can become part of an AI compliance dashboard.
The objective is not to replace established validation practices.
It is to extend proven compliance and data-integrity principles into AI workflows.
AI Compliance and the Client Data Training Paradox
AI adoption also raises an important question around client data.
If an AI system processes client information, does that information become part of the vendor's model or training environment?
The governance answer should begin with clear boundaries around data.
Organizations need safeguards that prevent one client's confidential information from appearing in another client's workflow or outputs.
This includes:
- Strong access controls
- Data segregation
- Defined data-use policies
- Appropriate agreements with LLM providers
- Cloud and infrastructure controls
- Protection of intellectual property
- Restrictions on model training and reuse
- Monitoring of data movement
The key question is not simply whether an AI system "learns."
It is:
What can the AI access, where can the information go, how can it be used, and what controls prevent inappropriate reuse?
That distinction is essential for AI compliance in life sciences.
Is More Governance Always Better?
In a regulated industry, reducing rigor is not the answer.
But applying identical controls to every AI use case can create unnecessary operational overhead.
The solution is proportional governance, not less governance.
Organizations are already dealing with pressure to move faster—to build new digital platforms, accelerate research, improve clinical workflows, and introduce AI into existing operations.
If governance becomes an obstacle, employees may find their own tools and workflows.
That creates the risk of shadow AI.
A stronger approach is to provide governed AI capabilities with clearly defined boundaries.
The objective is to govern what authority AI has within a workflow, rather than simply controlling whether AI exists.
Continuous AI Monitoring vs. Legacy Validation
Traditional validation often relied on rigid scripts, controlled software versions, and scheduled testing cycles.
Even deterministic systems are moving toward more automated and continuous approaches.
AI makes continuous monitoring even more relevant.
Instead of attempting to predict and test every possible generative output, organizations can combine:
- Continuous sampling
- Automated evaluation
- Output scoring
- Anomaly detection
- Human review
- Regression testing
- Performance monitoring
- Trend analysis
This allows organizations to identify problems as they emerge.
The objective is not necessarily to test every output.
It is to create sufficient monitoring and evaluation to detect meaningful deviations from expected performance.
AI-Assisted Validation: Using AI to Govern AI
AI can also support parts of the validation process.
For example, a separate evaluation system could be configured to identify specific categories of errors in an AI-generated output.
The important distinction is that this should not simply mean asking another general-purpose LLM whether an answer is "correct."
The evaluation should have:
- A defined purpose
- Defined evaluation criteria
- Known test conditions
- Appropriate controls
- Human oversight where necessary
For example, an evaluator could be instructed to identify five predefined classes of errors in a document and flag them for review.
This creates a more targeted form of AI-assisted validation.
AI becomes part of the governance infrastructure without becoming the sole authority responsible for determining whether AI is correct.
Choosing the Right AI Model for the Right Task
AI governance also has a cost dimension.
Not every task requires a frontier model.
A sophisticated model may be appropriate for complex reasoning, research, or advanced generation. But simpler tasks may be handled effectively by smaller or open models.
These can include:
- Classification
- Pattern detection
- Compliance checks
- Structured comparisons
- Monitoring
- Evaluation
- Defined validation tasks
This creates a practical principle for AI-native life sciences platforms:
Use the right model for the right job.
This approach can reduce token consumption while maintaining appropriate quality and governance.
Building an AI Governance Playbook for CXOs
For executives, AI governance needs to move beyond policy documents and become an operating model.
A practical AI governance framework for life sciences should answer seven questions.
- What can the AI do?
Define its permitted authority and boundaries.
- What happens if it is wrong?
Assess the potential consequence of failure.
- Where is human judgment required?
Identify mandatory human review and decision points.
- How is the AI qualified?
Establish quality thresholds and competency requirements before expanding its authority.
- How is performance monitored?
Use continuous sampling, automated evaluation, and human oversight where appropriate.
- What evidence is captured?
Maintain traceability across:
Input → Model → Output → Review → Decision → Action
- What model should be used?
Match model capability and cost to the complexity and risk of the task.
This turns AI governance from a compliance exercise into an operational capability.
The Economics of AI Governance: Managing the Token Budget
AI governance also requires organizations to understand the economics of inference.
Organizations are still learning how much model capacity different workflows actually require.
Using the most advanced model for every task can create unnecessary cost.
A more deliberate architecture can distribute workloads across frontier, open, and smaller models according to task complexity.
For example:
Complex reasoning → Frontier model
Defined task → Smaller or open model
Validation/evaluation → Purpose-built evaluator
This approach can significantly reduce token consumption.
A useful way to assess the economics is to compare AI costs against measurable productivity gains.
If an AI workflow gives a developer an additional productive hour during an eight-hour day, that productivity gain can be considered alongside the inference cost required to generate it.
The goal should not be maximum AI consumption.
It should be maximum governed AI leverage.
The Future of AI Governance Is Governance With AI
The next stage of AI governance will not simply be about governing AI.
It will also involve using AI to help govern AI.
AI can assist with:
- Compliance assessments
- Validation checks
- Documentation
- Traceability
- Output monitoring
- Risk classification
- Anomaly detection
- Continuous evaluation
For example, an AI-enabled compliance dashboard could assess a workflow against defined controls and identify areas that require additional human review.
The underlying validation process remains intact.
AI simply helps automate parts of the evidence collection, analysis, and monitoring.
This creates an opportunity for organizations to achieve greater transparency and continuous oversight without increasing manual effort at the same rate.
What Does the Future of AI Validation in Life Sciences Look Like?
AI is forcing life sciences organizations to rethink validation models built primarily for deterministic software.
That does not mean lowering standards.
It means asking better questions.
Instead of:
“Did the system produce the exact expected answer?”
The organization should ask:
“Did the system operate within its intended authority, produce an acceptable outcome, maintain appropriate controls, and provide sufficient evidence for human oversight and accountability?”
That shift enables:
- Risk-based AI governance
- Proportional validation
- Continuous monitoring
- Competency-based AI qualification
- Human-adjacent workflows
- AI-assisted validation
- Stronger data governance
- More efficient compliance operations
The Goal: Smarter Rigor, Not Less Rigor
The future of AI in life sciences will not be defined by choosing between innovation and compliance.
It will be defined by how effectively organizations integrate the two.
AI governance should not become another layer of bureaucracy added after a system has been built.
It should become part of the platform, workflow, and operating model from the beginning.
The objective is simple:
Move faster without losing control.
For life sciences organizations, that means AI systems that are risk-based, observable, continuously monitored, properly validated, and ultimately accountable to human judgment.
That is what responsible AI adoption looks like in a regulated industry.
